HEADER SIGNALING PROTEIN 09-APR-03 1OZN TITLE 1.5A CRYSTAL STRUCTURE OF THE NOGO RECEPTOR LIGAND BINDING DOMAIN TITLE 2 REVEALS A CONVERGENT RECOGNITION SCAFFOLD MEDIATING INHIBITION OF TITLE 3 MYELINATION CAVEAT 1OZN NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETICULON 4 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: NOGO RECEPTOR, NGR, NOGO-66 RECEPTOR; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RTN4R OR NOGOR; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HI5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PACGP67A KEYWDS NOGO RECEPTOR, MAD, MYELINATION INHIBITION, OMGP, MAG, NOGO-66, P75, KEYWDS 2 SIGNAL TRANSDUCTION, NEURONAL REGENERATION, LIGAND BINDING, KEYWDS 3 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.HE,J.F.BAZAN,J.B.PARK,G.MCDERMOTT,Z.HE,K.C.GARCIA REVDAT 4 29-JUL-20 1OZN 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 1OZN 1 VERSN REVDAT 2 24-FEB-09 1OZN 1 VERSN REVDAT 1 20-MAY-03 1OZN 0 JRNL AUTH X.L.HE,J.F.BAZAN,G.MCDERMOTT,J.B.PARK,K.WANG, JRNL AUTH 2 M.TESSIER-LAVIGNE,Z.HE,K.C.GARCIA JRNL TITL STRUCTURE OF THE NOGO RECEPTOR ECTODOMAIN. A RECOGNITION JRNL TITL 2 MODULE IMPLICATED IN MYELIN INHIBITION. JRNL REF NEURON V. 38 177 2003 JRNL REFN ISSN 0896-6273 JRNL PMID 12718853 JRNL DOI 10.1016/S0896-6273(03)00232-0 REMARK 2 REMARK 2 RESOLUTION. 1.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1634 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.52 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.62 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 262 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2219 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 101 REMARK 3 SOLVENT ATOMS : 354 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.90000 REMARK 3 B22 (A**2) : 1.51000 REMARK 3 B33 (A**2) : -2.42000 REMARK 3 B12 (A**2) : -3.31000 REMARK 3 B13 (A**2) : -1.55000 REMARK 3 B23 (A**2) : 1.90000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.15 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.990 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OZN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000018843. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0064, 1.0096, 0.9950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33484 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.520 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 14.40 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 13.80 REMARK 200 R MERGE FOR SHELL (I) : 0.21400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, SODIUM CHLORIDE, SODIUM REMARK 280 ACETATE, PH 6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE NOGO RECEPTOR LIGAND BINDING DOMAIN BINDS MYELIN REMARK 300 INHIBTORS SUCH AS NOGO, OMGP AND MAG REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 310 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 30 -4.88 82.85 REMARK 500 ASN A 67 -162.20 -108.05 REMARK 500 ASN A 91 -151.78 -115.80 REMARK 500 LEU A 104 53.21 -97.53 REMARK 500 ARG A 119 -40.75 63.49 REMARK 500 ASN A 164 -151.17 -115.09 REMARK 500 ASP A 172 19.47 59.47 REMARK 500 ASN A 188 -163.68 -120.05 REMARK 500 ASN A 212 -154.98 -126.81 REMARK 500 LEU A 225 54.23 -91.20 REMARK 500 ASP A 265 -149.07 -119.12 REMARK 500 REMARK 500 REMARK: NULL DBREF 1OZN A 26 310 UNP Q9BZR6 RT4R_HUMAN 26 310 SEQRES 1 A 285 PRO CYS PRO GLY ALA CYS VAL CYS TYR ASN GLU PRO LYS SEQRES 2 A 285 VAL THR THR SER CYS PRO GLN GLN GLY LEU GLN ALA VAL SEQRES 3 A 285 PRO VAL GLY ILE PRO ALA ALA SER GLN ARG ILE PHE LEU SEQRES 4 A 285 HIS GLY ASN ARG ILE SER HIS VAL PRO ALA ALA SER PHE SEQRES 5 A 285 ARG ALA CYS ARG ASN LEU THR ILE LEU TRP LEU HIS SER SEQRES 6 A 285 ASN VAL LEU ALA ARG ILE ASP ALA ALA ALA PHE THR GLY SEQRES 7 A 285 LEU ALA LEU LEU GLU GLN LEU ASP LEU SER ASP ASN ALA SEQRES 8 A 285 GLN LEU ARG SER VAL ASP PRO ALA THR PHE HIS GLY LEU SEQRES 9 A 285 GLY ARG LEU HIS THR LEU HIS LEU ASP ARG CYS GLY LEU SEQRES 10 A 285 GLN GLU LEU GLY PRO GLY LEU PHE ARG GLY LEU ALA ALA SEQRES 11 A 285 LEU GLN TYR LEU TYR LEU GLN ASP ASN ALA LEU GLN ALA SEQRES 12 A 285 LEU PRO ASP ASP THR PHE ARG ASP LEU GLY ASN LEU THR SEQRES 13 A 285 HIS LEU PHE LEU HIS GLY ASN ARG ILE SER SER VAL PRO SEQRES 14 A 285 GLU ARG ALA PHE ARG GLY LEU HIS SER LEU ASP ARG LEU SEQRES 15 A 285 LEU LEU HIS GLN ASN ARG VAL ALA HIS VAL HIS PRO HIS SEQRES 16 A 285 ALA PHE ARG ASP LEU GLY ARG LEU MET THR LEU TYR LEU SEQRES 17 A 285 PHE ALA ASN ASN LEU SER ALA LEU PRO THR GLU ALA LEU SEQRES 18 A 285 ALA PRO LEU ARG ALA LEU GLN TYR LEU ARG LEU ASN ASP SEQRES 19 A 285 ASN PRO TRP VAL CYS ASP CYS ARG ALA ARG PRO LEU TRP SEQRES 20 A 285 ALA TRP LEU GLN LYS PHE ARG GLY SER SER SER GLU VAL SEQRES 21 A 285 PRO CYS SER LEU PRO GLN ARG LEU ALA GLY ARG ASP LEU SEQRES 22 A 285 LYS ARG LEU ALA ALA ASN ASP LEU GLN GLY CYS ALA MODRES 1OZN ASN A 82 ASN GLYCOSYLATION SITE MODRES 1OZN ASN A 179 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NDG B 2 14 HET MAN B 3 11 HET MAN B 4 11 HET NAG C 1 14 HET NDG C 2 14 HET BMA C 3 11 HET ACY A 1 4 HET ACY A 2 4 HET ACY A 3 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM ACY ACETIC ACID FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 NDG 2(C8 H15 N O6) FORMUL 2 MAN 2(C6 H12 O6) FORMUL 3 BMA C6 H12 O6 FORMUL 4 ACY 3(C2 H4 O2) FORMUL 7 HOH *354(H2 O) HELIX 1 1 PRO A 242 ALA A 247 1 6 HELIX 2 2 ASP A 265 ARG A 267 5 3 HELIX 3 3 ALA A 268 PHE A 278 1 11 HELIX 4 4 PRO A 290 ALA A 294 5 5 HELIX 5 5 ASP A 297 LEU A 301 5 5 HELIX 6 6 ALA A 302 LEU A 306 5 5 SHEET 1 A12 VAL A 32 TYR A 34 0 SHEET 2 A12 THR A 40 SER A 42 -1 O SER A 42 N VAL A 32 SHEET 3 A12 ARG A 61 PHE A 63 1 O ARG A 61 N THR A 41 SHEET 4 A12 ILE A 85 TRP A 87 1 O TRP A 87 N ILE A 62 SHEET 5 A12 GLN A 109 ASP A 111 1 O GLN A 109 N LEU A 86 SHEET 6 A12 THR A 134 HIS A 136 1 O HIS A 136 N LEU A 110 SHEET 7 A12 TYR A 158 TYR A 160 1 O TYR A 160 N LEU A 135 SHEET 8 A12 HIS A 182 PHE A 184 1 O HIS A 182 N LEU A 159 SHEET 9 A12 ARG A 206 LEU A 208 1 O ARG A 206 N LEU A 183 SHEET 10 A12 THR A 230 TYR A 232 1 O THR A 230 N LEU A 207 SHEET 11 A12 TYR A 254 ARG A 256 1 O TYR A 254 N LEU A 231 SHEET 12 A12 SER A 281 SER A 282 1 O SER A 281 N LEU A 255 SHEET 1 B 2 HIS A 71 VAL A 72 0 SHEET 2 B 2 ARG A 95 ILE A 96 1 O ARG A 95 N VAL A 72 SHEET 1 C 2 SER A 192 VAL A 193 0 SHEET 2 C 2 HIS A 216 VAL A 217 1 O HIS A 216 N VAL A 193 SHEET 1 D 2 TRP A 262 VAL A 263 0 SHEET 2 D 2 CYS A 287 LEU A 289 1 O SER A 288 N TRP A 262 SSBOND 1 CYS A 27 CYS A 33 1555 1555 2.05 SSBOND 2 CYS A 31 CYS A 43 1555 1555 2.04 SSBOND 3 CYS A 264 CYS A 287 1555 1555 2.04 SSBOND 4 CYS A 266 CYS A 309 1555 1555 2.03 LINK ND2 ASN A 82 C1 NAG B 1 1555 1555 1.46 LINK ND2 ASN A 179 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NDG B 2 1555 1555 1.40 LINK O4 NDG B 2 C1 MAN B 3 1555 1555 1.40 LINK O6 MAN B 3 C1 MAN B 4 1555 1555 1.40 LINK O4 NAG C 1 C1 NDG C 2 1555 1555 1.39 LINK O4 NDG C 2 C1 BMA C 3 1555 1555 1.39 CISPEP 1 GLU A 36 PRO A 37 0 0.24 CISPEP 2 LEU A 289 PRO A 290 0 -0.57 CRYST1 32.206 33.915 60.221 85.02 75.91 67.96 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031050 -0.012570 -0.007857 0.00000 SCALE2 0.000000 0.031810 0.000161 0.00000 SCALE3 0.000000 0.000000 0.017121 0.00000